Irvine CA 前列腺癌临床试验
14项针对 前列腺癌的研究正在 Irvine及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
招募中3 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
招募中2 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- CHAO Family Comprehensive Cancer Center and Ambulatory Care ( Site 0120), Irvine
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
招募中3 期
- UCLA Hematology/Oncology - Irvine, Irvine
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
招募中3 期
- City of Hope Lennar Foundation Cancer Center ( Site 0059), Irvine
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
招募中1 期
- Hoag Memorial Hospital Presbyterian, Irvine
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
招募中3 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
Daily Adaptive Radiation Therapy Using an Individualized Approach for Prostate Cancer
招募中
- City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Testing the Effects of Exercise on Colorectal Cancer Development After Treatment With Pelvic Radiation Therapy for Prostate Cancer
招募中
- City of Hope at Irvine Lennar, Irvine
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
招募中3 期
- Research Site, Irvine
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
招募中3 期
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- City of Hope at Irvine Lennar, Irvine
- Kaiser Permanente-Irvine, Irvine
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
招募中2 期
- City of Hope at Irvine Lennar, Irvine
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中观察性研究
- Massive Bio SYNERGY-AI site, Irvine
PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
招募中2 期
- Hoag Memorial Hospital Presbyterian, Irvine
其他城市的 前列腺癌试验
- New York City, NY103 项研究
- Houston, TX76 项研究
- Los Angeles, CA61 项研究
- Boston, MA59 项研究
- St. Louis, MO46 项研究
- Chicago, IL45 项研究
- San Francisco, CA45 项研究
- Philadelphia, PA44 项研究
- Baltimore, MD43 项研究
- Nashville, TN43 项研究
- Seattle, WA42 项研究
- Washington, DC38 项研究
Irvine的其他研究
- 非小细胞肺癌25 项研究
- 乳腺癌23 项研究
- 癌症（所有类型）17 项研究
- 转移性癌症16 项研究
- 肺癌15 项研究
- 多发性骨髓瘤14 项研究
- 卵巢癌12 项研究
- 头颈鳞状细胞癌11 项研究
- 膀胱癌11 项研究
- 阿尔茨海默病11 项研究
- 结直肠癌10 项研究
- 胰腺癌10 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。